BPA Call 36C24924A0002-36C24924N0048
Award Date 10/1/23
Potential Completion Date 9/30/24
Potential Value $775K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Fishers, IN 46037, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to Telix Pharmaceuticals US Inc., a global biopharmaceutical company, by the U.S. Department of Veterans Affairs (VA) through its Veterans Health Administration (VHA). The contract, with a ceiling value of $858,000.00, is for the delivery of various radiopharmaceuticals to support the VA's nuclear medicine and medical imaging services for veterans. The contract is a Blanket Purchase Agreement (BPA) call order awarded under a larger $17.5 million BPA the company...
- This is a firm fixed price delivery order awarded to Telix Pharmaceuticals US Inc. by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) with a ceiling value of $165,000.00. The contract is for the supply of Telix's radiopharmaceutical products, including Illuccix for prostate cancer imaging and Gozetotide for other nuclear medicine procedures, to VA medical facilities across the country. This award is part of Telix's broader contract vehicles with the VA, which include...
- The Department of Veterans Affairs, Veterans Integrated Service Network 9 (VISN 9) has awarded Telix Pharmaceuticals US Inc. a Blanket Purchase Agreement (BPA) call order valued at $857.5K for the supply of various radiopharmaceuticals. The contract, effective October 1, 2025, with an ultimate completion date of September 30, 2026, operates as a firm fixed-price delivery order without small business set-aside designation. Telix Pharmaceuticals, headquartered in Fishers, Indiana, will perform the...
- This is a firm fixed price delivery order awarded to Telix Pharmaceuticals US Inc. by the Department of Veterans Affairs (VA) in the amount of $334,300.00. The award is for the delivery of Illuccix, a radiopharmaceutical used for prostate cancer imaging, to support the VA's nuclear medicine and medical imaging services. The award was issued under Telix's existing $17.5 million Blanket Purchase Agreement (BPA) with the VA National Acquisition Center, as well as the company's other contract...
- Telix Pharmaceuticals US Inc. has been awarded a $479,500 firm fixed price delivery order against a Blanket Purchase Agreement to provide radiopharmaceutical Illuccix for prostate cancer imaging services. The order was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 located in Dublin, Ohio, with a completion date of November 6, 2023. As a manufacturer of radiopharmaceutical goods, Telix Pharmaceuticals supports nuclear medicine...
- The Department of Veterans Affairs, Veterans Integrated Service Network 8 (VISN 8), awarded a BPA call order to Telix Pharmaceuticals US Inc. for $1.14M on October 1, 2024, with a completion date of September 30, 2025. This firm fixed-price contract, awarded without a set-aside designation, covers the supply of Illuccix, a radiopharmaceutical product used for prostate cancer imaging in nuclear medicine applications. The contract work will be performed at Telix Pharmaceuticals' facility in...
- <p>The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 (VA - VHA) awarded a $665,200 firm fixed price delivery order contract to Telix Pharmaceuticals US Inc. to provide ILLUCCIX (MEDICATION) ORDER. The contract has a period of performance from July 11, 2022 through October 31, 2022 and will be performed at the VETERANS ADMINISTRATION facility located in West Los Angeles, California.</p>
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 (VA - VHA) awarded a $385,000 Delivery Order contract to Telix Pharmaceuticals US Inc. to provide Emergency ILLUCCIX (Nuclear Medicine) for the VA San Diego Healthcare System located in San Diego, California. The firm fixed price contract runs from July 19, 2022 through June 9, 2023 and tasks the prime contractor, Telix Pharmaceuticals US Inc., with supplying nuclear medicine products to...
- This is a Blanket Purchase Agreement (BPA) call order awarded by the Department of Veterans Affairs (VA) to Advanced Accelerator Applications USA Inc., a subsidiary of Novartis and a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The contract, with a ceiling value of $977,749.98, is for the delivery of PLUVICTO doses in Calendar Year 2024. This order falls under the parent GSA Schedule 61-IB, Pharmaceuticals and Drugs, and is priced on a Firm...
- This is a firm-fixed-price blanket purchase agreement (BPA) call awarded to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a for-profit small disadvantaged business, by the U.S. Department of Veterans Affairs (VA). The contract is for the delivery of radiopharmaceuticals, including Ga-68 Dotatate, iodine I-123, technetium-99m, and other medical isotopes used in nuclear medicine procedures, diagnostic imaging, and cancer treatment across the VA's nationwide...